New asthma inhalers

There have been several new asthma inhalers approved in recent years, offering improved treatment options for people with asthma. Here are some of the latest developments:

  1. Fasenra (benralizumab): An injectable biologic medication that targets eosinophils, a type of white blood cell that plays a key role in asthma inflammation. Fasenra is approved for severe asthma patients who require oral corticosteroids.
  2. Nucala (mepolizumab): Another injectable biologic medication that targets eosinophils. Nucala is approved for severe asthma patients who require oral corticosteroids and have a high level of eosinophils in their sputum.
  3. Cinqair (reslizumab): An injectable biologic medication that targets eosinophils. Cinqair is approved for severe asthma patients who require oral corticosteroids and have a high level of eosinophils in their sputum.
  4. Trekella (lebrikizumab): An injectable biologic medication that targets interleukin-13 (IL-13), a protein involved in asthma inflammation. Trekella is approved for severe asthma patients who require oral corticosteroids.
  5. GSK's investigational biologic: GlaxoSmithKline (GSK) is developing an investigational biologic medication that targets IL-4 and IL-13. This medication has shown promise in reducing asthma symptoms and improving lung function in clinical trials.
  6. Novartis's investigational biologic: Novartis is developing an investigational biologic medication that targets IL-4 and IL-13. This medication has shown promise in reducing asthma symptoms and improving lung function in clinical trials.
  7. Inhalers with built-in sensors: Some new inhalers, such as the Propeller Health inhaler, come equipped with built-in sensors that track medication use and provide real-time feedback to patients and healthcare providers.
  8. Dry powder inhalers (DPIs): DPIs, such as the Ellipta inhaler, are designed to deliver medication directly to the lungs, reducing the risk of side effects and improving treatment outcomes.
  9. Soft mist inhalers: Soft mist inhalers, such as the Respimat inhaler, use a unique technology to deliver medication in a soft, gentle mist that is easy to inhale.
  10. Inhalers with improved delivery systems: Some new inhalers, such as the Eklira inhaler, use advanced delivery systems that improve the accuracy and efficiency of medication delivery.

These are just a few examples of the new asthma inhalers that have been approved or are in development. It's essential for patients to work closely with their healthcare providers to determine the best treatment plan for their specific needs.